News AZ backs up threat of manufacturing shift from Europe AstraZeneca has said it is considering a shift in the production of some medicines from Europe to the US in order to sidestep potential tariffs.
News AbbVie makes its tariffs-driven investment play AbbVie has become the latest pharma group to make a big capital investment announcement in the US and court favour with the Trump administration.
R&D Bridging the lab gap: Expanding access to cutting-edge resea... The global demand for state-of-the-art research facilities is limited by the current supply, leaving many regions unable to support innovation outside of established hubs like Boston, San D
News Report says US biotech needs $15bn support to fend off China The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.
News Chiesi backs growth plans with a €430m new plant in Italy Fast-growing pharma group Chiesi has revealed plans to spend €430m on a new therapeutics manufacturing facility at its site in Milan.
News AZ builds in China, as J&J ramps up its US investments AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.